dr. M. (Marco) de Bruyn

Associate professor

Faculty of Medical Sciences

Telephone:

+31 50 361 3174

E-mail:

m.de.bruyn umcg.nl

Homepage ORCID Research Portal

Publications

Biomarker and transcriptomics profiles of serum selenium concentrations in patients with heart failure are associated with immunoregulatory processes

Al-Mubarak, A. A., Markousis Mavrogenis, G., Guo, X., De Bruyn, M., Nath, M., Romaine, S. P. R., Grote Beverborg, N., Arevalo Gomez, K., Zijlstra, S. N., van Veldhuisen, D. J., Samani, N. J., Voors, A. A., van der Meer, P. & Bomer, N., Apr-2024, In: Redox Biology. 70, 10 p., 103046.

Research output: Contribution to journal › Article › Academic › peer-review

Correction to: Prediction of recurrence risk in endometrial cancer with multimodal deep learning (Nature Medicine, (2024), 10.1038/s41591-024-02993-w)

Volinsky-Fremond, S., Horeweg, N., Andani, S., Barkey Wolf, J., Lafarge, M. W., de Kroon, C. D., Ørtoft, G., Høgdall, E., Dijkstra, J., Jobsen, J. J., Lutgens, L. C. H. W., Powell, M. E., Mileshkin, L. R., Mackay, H., Leary, A., Katsaros, D., Nijman, H. W., de Boer, S. M., Nout, R. A. & de Bruyn, M.& 5 others, Church, D., Smit, V. T. H. B. M., Creutzberg, C. L., Koelzer, V. H. & Bosse, T., Jul-2024, In: Nature Medicine. 30, 7, p. 2092 1 p.

Research output: Contribution to journal › Erratum

ImmunoPET provides a novel way to visualize the CD103+ tissue-resident memory T cell to predict the response of immune checkpoint inhibitors.

Fan, X., Nijman, H. W., de Bruyn, M. & Elsinga, P. H., 5-Jan-2024, In: EJNMMI Research. 14, 1, 11 p., 5.

Research output: Contribution to journal › Review article › peer-review

Prediction of recurrence risk in endometrial cancer with multimodal deep learning

Research output: Contribution to journal › Article › Academic › peer-review

Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing act

Tiersma, J. F., Evers, B., Bakker, B. M., Reijngoud, D. J., de Bruyn, M., de Jong, S. & Jalving, M., Sept-2024, In: CANCER TREATMENT REVIEWS. 129, 11 p., 102802.

Research output: Contribution to journal › Review article › peer-review

Corrigendum to “NEAT1: Culprit lncRNA linking PIG[sbnd]C, MSLN, and CD80 in triple-negative breast cancer”

Hussein, N. H., Armanious, M., Eissa, R. A., de Bruyn, M. & El Tayebi, H. M., 1-Nov-2023, In: Life Sciences. 332, 1 p., 122133.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors

Ważyńska, M. A., Butera, R., Requesens, M., Plat, A., Zarganes-Tzitzikas, T., Neochoritis, C. G., Plewka, J., Skalniak, L., Kocik-Krol, J., Musielak, B., Magiera-Mularz, K., Rodriguez, I., Blok, S. N., de Bruyn, M., Nijman, H. W., Elsinga, P. H., Holak, T. A. & Dömling, A., 27-Jul-2023, In: Journal of Medicinal Chemistry. 66, 14, p. 9577-9591 15 p.

Research output: Contribution to journal › Article › Academic › peer-review

Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET

Fan, X., Ważyńska, M. A., Kol, A., Perujo Holland, N., Fernandes, B., van Duijnhoven, S. M. J., Plat, A., van Eenennaam, H., Elsinga, P. H., Nijman, H. W. & de Bruyn, M., 20-Nov-2023, In: EJNMMI Research. 13, 1, 11 p., 100.

Research output: Contribution to journal › Article › Academic › peer-review

EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells

Melo, V., Nelemans, L. C., Vlaming, M., Lourens, H. J., Wiersma, V. R., Bilemjian, V., Huls, G., de Bruyn, M. & Bremer, E., 20-Jul-2023, In: Frontiers in Immunology. 14, 16 p., 1191866.

Research output: Contribution to journal › Article › Academic › peer-review